<h4>Background</h4>Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are associated with increased heart rate (HR) and reduced heart rate variability (HRV) in patients with type 2 diabetes mellitus (T2DM). The gene discussed is GLP1R; the disease is type 2 diabetes mellitus.